References
Appelrouth DJ, Bairn S, Chang RW, Cohen MH, England DW, et al. Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults. American Journal of Medicine 83 (Suppl. 4B): 78–81, 1987
Boyle EA, Freeman PC, Mangan FR, Thomson MJ. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent. Journal of Pharmacy and Pharmacology 34 (Suppl.): 74P, 1982
Hazleman BL, Thomas PP. Single-blind comparative study of Relafen (nabumetone) against Naproxen in the treatment of rheumatoid arthritis. American Journal of Medicine 83 (Suppl. 4B): 60–64, 1987
Verbruggen LA, Cytryn E, Pintens H. Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis. Journal of International Medical Research 10: 214–218, 1982
Wade AG, Fletcher DM. Comparison of nabumetone and indomethacin in the treatment of patients in general practice with osteoarthritis. Royal Society of Medicine International Congress and Symposium Series 69: 149–160, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaiani, G., Grossi, E. Meta-Analysis of Italian Clinical Trials of Nabumetone. Med Toxicol Adverse Drug Exp 40 (Suppl 5), 48–49 (1990). https://doi.org/10.2165/00003495-199000405-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199000405-00011